Liberty Biopharma (CVE:LTY) Stock Crosses Above Fifty Day Moving Average – Here’s What Happened

Liberty Biopharma Inc (CVE:LTY) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.

Liberty Biopharma Trading Up ∞

The company’s 50-day moving average price is C$2.00 and its 200-day moving average price is C$2.00. The firm has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19.

Liberty Biopharma Company Profile

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.